Functional, cognitive and behavioral benefits of donepezil inpatients with moderate Alzheimer's disease.

被引：0
|
作者：
Feldman, H
Gauthier, S
Hecker, J
Vellas, B
Emir, B
Subbiah, P
机构：
[1] Univ British Columbia, Div Neurol, Vancouver, BC V5Z 1M9, Canada
[2] McGill Ctr Studies Aging, Verdun, PQ, Canada
[3] Repatriat Gen Hosp, Daw Pk, Australia
[4] Toulouse Univ, Alzheimers Ctr, Toulouse, France
[5] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2002年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
P286
引用
收藏
页码：S104 / S105
页数：2
相关论文
共 50 条
  • [1] Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Emir, B
    Subbiah, P
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (06) : 347 - 354
  • [2] Significant behavioral benefits with continued donepezil treatment in patients with mild-to-moderate Alzheimer's disease.
    Nunez, M
    Barcikowska, M
    Dautzenberg, P
    Heun, R
    Jakobsen, S
    Karageorgiou, C
    Triau, E
    Tury, F
    Qvitzau, S
    Richardson, S
    Xu, Y
    Schwam, E
    Schindler, R
    Johannsen, P
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S76 - S76
  • [3] Efficacy of donepezil on functional, behavioral, and cognitive symptoms in patients with moderate to severe Alzheimer's disease
    Gauthier, S
    Feldman, H
    Hecker, J
    Vellas, B
    Subbiah, P
    Whalen, E
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S2 - S2
  • [4] Donepezil benefits patients with moderate to severe Alzheimer's disease
    Watts, Geoff
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [5] Pharmacoeconomic benefits of donepezil treatment in severe Alzheimer's disease.
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Hux, M
    Xu, Y
    Schwam, E
    Leaderer, M
    Shah, SN
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S149 - S150
  • [6] Donepezil treatment benefits in early stage Alzheimer's disease.
    Seltzer, B
    Zolnouni, P
    Nunez, M
    Goldman, R
    Kumar, D
    Ieni, J
    Richardson, S
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S100 - S101
  • [7] Donepezil has significant functional and behavioral benefits in patients with severe Alzheimer's disease
    Feldman, H
    Gauthier, S
    Hecker, J
    Vellas, B
    Xu, Y
    Ieni, J
    Schwam, E
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S402 - S402
  • [8] Behavioral benefits with continued donepezil treatment in Alzheimer's disease patients
    Johanssen, P.
    Hasselbalch, S.
    Jakab, G.
    Kalisvaart, C. J.
    Kozubski, W.
    Kurz, A.
    McCarthy, J.
    Triau, E.
    Tsolaki, M.
    Qvitzau, S.
    Richardson, S.
    Xu, Y.
    Schwam, E.
    Schindler, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 184 - 184
  • [9] Behavioral benefits with continued donepezil treatment in Alzheimer's disease patients
    Johannsen, P
    Holub, R
    Jakab, G
    Jakobsen, S
    Kalisvaart, CJ
    Kozubski, W
    Kurz, A
    Triau, E
    Tsolaki, M
    Bergendorff, L
    Xu, Y
    Kumar, N
    Richardson, S
    NEUROBIOLOGY OF AGING, 2004, 25 : S20 - S20
  • [10] Comparison of functional and cognitive donepezil effects in Alzheimer's disease
    Saine, K
    Cullum, CM
    Martin-Cook, K
    Hynan, L
    Svetlik, DA
    Weiner, MF
    INTERNATIONAL PSYCHOGERIATRICS, 2002, 14 (02) : 181 - 185
12345